DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Kurikawa N, Suga M, Kuroda S, Yamada K, Ishikawa H.
An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.

Br J Pharmacol 2003;
139 (06) 1085-1094

Download Bibliographical Data

Access:
Access:
Access: